asco23 - lba2: prospect neoadjuvant cr vs. neoadjuvant folfox ct with selective use of cr, follo...
Published 1 year ago • 516 plays • Length 7:40Download video MP4
Download video MP3
Similar videos
-
0:46
prospect: neoadjuvant crt vs folfox in locally advanced rectal cancer
-
11:42
asco daily news 2023 plenary update - lba2: prospect
-
9:55
asco 2023 expert report on novelties in the treatment of colorectal cancer by s. stintzing
-
1:51
folfox with 5fucrt is non-inferior to 5fucrt for treatment of larc
-
3:00
foxtrot: neoadjuvant folfox chemotherapy in colorectal cancer
-
1:23
immunotherapy at asco 2023: updates in neoadjuvant and adjuvant therapy
-
8:34
neoadjuvant chemo with mfolfirinox shows survival benefit in locally advanced rectal cancer
-
0:11
life of young colon cancer survivor
-
1:07
updates in adjuvant and neoadjuvant treatment for colon cancer
-
1:00
key takeaways from asco 2024: advances in kidney cancer biomarkers and neoadjuvant therapy
-
0:59
practical considerations for genomic testing in colorectal cancer
-
3:46
overview of rapido trial in rectal cancer and foxtrot trial in colon cancer
-
1:07
the benefits and pitfalls of total neoadjuvant therapy in rectal cancer
-
3:26
elucidating the optimal total neoadjuvant therapy in rectal cancer
-
3:00
neoadjuvant and adjuvant chemotherapy with tme in t3 rectal cancer
-
9:16
keynote-522: pembro ct vs placebo ct neoadjuvant followed adjuvant pembro vs placebo in tnbc
-
1:08
the role of neoadjuvant immunotherapy in msi-high gastric cancer